North Rock Partners, LLC Gilead Sciences, Inc. Transaction History

North Rock Partners, LLC

  • $1.14 Billion
  • Q3 2024

A detailed history of North Rock Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, North Rock Partners, LLC holds 2,947 shares of GILD stock, worth $269,208. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,947
Previous 3,784 22.12%
Holding current value
$269,208
Previous $259,000 4.63%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$66.59 - $83.99 $55,735 - $70,299
-837 Reduced 22.12%
2,947 $247,000
Q2 2024

Aug 06, 2024
SELL
$63.15 - $72.88 $11,619 - $13,409
-184 Reduced 4.64%
3,784 $259,000
Q1 2024

May 07, 2024
SELL
$71.58 - $87.29 $126,267 - $153,979
-1,764 Reduced 30.77%
3,968 $290,000
Q4 2023

Feb 08, 2024
BUY
$73.27 - $83.09 $140,385 - $159,200
1,916 Added 50.21%
5,732 $464,000
Q3 2023

Oct 24, 2023
BUY
$73.94 - $80.67 $7,098 - $7,744
96 Added 2.58%
3,816 $285,000
Q2 2023

Aug 02, 2023
SELL
$76.01 - $86.7 $35,724 - $40,749
-470 Reduced 11.22%
3,720 $286,000
Q1 2023

May 03, 2023
SELL
$77.31 - $88.08 $45,071 - $51,350
-583 Reduced 12.21%
4,190 $347,000
Q4 2022

Feb 01, 2023
BUY
$62.32 - $89.47 $39,448 - $56,634
633 Added 15.29%
4,773 $409,000
Q3 2022

Nov 02, 2022
BUY
$59.54 - $68.01 $26,495 - $30,264
445 Added 12.04%
4,140 $255,000
Q2 2022

Aug 04, 2022
BUY
$57.72 - $65.01 $213,275 - $240,211
3,695 New
3,695 $228,000
Q1 2022

May 05, 2022
SELL
$57.92 - $72.58 $160,322 - $200,901
-2,768 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$64.88 - $73.64 $230,583 - $261,716
-3,554 Reduced 56.22%
2,768 $201,000
Q3 2021

Nov 12, 2021
BUY
$67.69 - $73.03 $68,299 - $73,687
1,009 Added 18.99%
6,322 $442,000
Q2 2021

Aug 12, 2021
BUY
$63.47 - $69.35 $337,216 - $368,456
5,313 New
5,313 $366,000
Q3 2020

Nov 12, 2020
SELL
$62.1 - $78.08 $222,752 - $280,072
-3,587 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$72.34 - $84.0 $289 - $336
4 Added 0.11%
3,587 $276,000
Q2 2020

Aug 11, 2020
BUY
$72.34 - $84.0 $45,429 - $52,752
628 Added 21.25%
3,583 $276,000
Q1 2020

May 13, 2020
SELL
$62.63 - $80.22 $592,730 - $759,202
-9,464 Reduced 76.21%
2,955 $221,000
Q4 2019

Feb 12, 2020
SELL
$61.62 - $67.78 $59,031 - $64,933
-958 Reduced 7.16%
12,419 $807,000
Q4 2019

Feb 12, 2020
BUY
$61.62 - $67.78 $109,745 - $120,716
1,781 Added 15.36%
13,377 $807,000
Q3 2019

Nov 12, 2019
BUY
$62.51 - $69.0 $724,865 - $800,124
11,596 New
11,596 $735,000

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email